haloperidol decanoate: Clinical Trials

2 trials of haloperidol decanoate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Unknown 1
Phase 11Unknown 1

Follow haloperidol decanoate: new trials by email Literature Review of haloperidol decanoate trials Research Report on haloperidol decanoate

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia
Jobelyn, Haloperidol - Schizophrenia and Disorders With Psychotic Features
Phase 1 / Phase 2UnknownFederal Neuro-Psychiatric Hospital, Yaba1002017-06-012017-02-16
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
Lorazepam, Placebo, Haloperidol decanoate - Advanced Cancers
Phase 2Active not recruitingM.D. Anderson Cancer Center932014-01-012026-07-17

Conditions studied

Delirium (1)  ·  Hematologic Neoplasms (1)  ·  Neurotoxicity Syndromes (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)

Sponsors

Federal Neuro-Psychiatric Hospital, Yaba (1)  ·  M.D. Anderson Cancer Center (1)

Countries

Nigeria (1)  ·  United States (1)

Top investigators

David Hui, MD (1)  ·  Moses Ojo, M.D. (1)

Results publications

PMID 28975307

NIH funding

R21CA186000 (1)